Mineralys Therapeutics, Inc. (MLYS) Financials
MLYS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 652.9 million | 14.7 million |
| Dec. 31, 2025 | 661.8 million | 15.1 million |
| Sept. 30, 2025 | 599.9 million | 23.5 million |
| June 30, 2025 | 335.7 million | 22.2 million |
MLYS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -39.5 million | 6.5 million |
| Dec. 31, 2025 | -37.9 million | 5.3 million |
| Sept. 30, 2025 | -28.9 million | 5.8 million |
| June 30, 2025 | -30.2 million | 4.6 million |
MLYS Net Income
No data available :(
MLYS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 646.1 million | - | - |
| Dec. 31, 2025 | 656.6 million | - | - |
| Sept. 30, 2025 | 217.6 million | - | - |
| June 30, 2025 | 324.9 million | - | - |
MLYS Shares Outstanding
MLYS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 24.4 million | 21.0 million | - |
| Dec. 31, 2025 | 15000 | 24.4 million | 13.9 million | - |
| Sept. 30, 2025 | - | 31.5 million | 9.7 million | - |
| June 30, 2025 | - | 38.3 million | 8.5 million | - |
MLYS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 6000 |
| Dec. 31, 2025 | - | 13000 |
| Sept. 30, 2025 | - | 15000 |
| June 30, 2025 | - | 16000 |
MLYS
Price: $23.92
52 week price:
Earnings Per Share: -1.97 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.7 billion